Thermo Fisher Scientific

This Valentine's Day, we celebrate our love for science and the incredible innovators who make life-changing discoveries possible through relentless research and cutting-edge advancements. We are inspired everyday by scientists around the world whose ingenuity and dedication help shape a brighter future for all.

Advances in personalized medicine have the potential to change the way patients are treated for cancer and other diseases. In order to realize the full potential of innovations like tailored treatment options and targeted drug development, we need to focus on technologies that streamline data analysis as well as collaborative partnerships across the healthcare, research, and technology sectors, says Thermo Fisher's Kathy Davy. It is also important to develop education that empowers clinical teams to implement precision medicine effectively, Davy adds. Read more about how, according to Davy, a focus in these areas can help ensure "that more patients benefit from the breakthroughs in oncology and beyond." https://lnkd.in/eziPtNwY

Understanding tissue structure and function is crucial to help researchers develop new treatments for solid tumors and neurodegenerative diseases. The recently launched Invitrogen EVOS S1000 Spatial Imaging System leverages advanced and patented spectral technology, helping to reduce the need for multiple rounds of imaging and preserve tissue integrity. Through this innovation, we're helping more researchers access high-quality data, enabling them to make important discoveries that could change the way we treat disease. Read more: https://lnkd.in/g-C3M9_R

On International Day of Women and Girls in Science, we recognize innovators like 14-year-old Tina Jin, a passionate young engineer determined to increase access to clean water. Tina immediately wanted to help after learning that a third of the world’s population lacks access to potable water, and that unsafe drinking water kills more people globally each year than natural disasters and conflicts combined. Relying on her STEM acumen, Tina invented a low-cost water filtration system that uses readily available, natural materials to make dirty water safe to drink. Her efforts earned her first place in the 2024 Thermo Fisher Scientific Junior Innovators Challenge, the nation’s premier STEM research competition for middle schoolers. Role models like Tina are an inspiration to us and we can’t wait to see how she, along with the next generation of scientific innovators, change the world. Read Tina's story here: https://lnkd.in/gnjecsYD Society for Science

Teamwork, collaboration and inspiration were key drivers of success for all of our 2025 Annual Leadership Award winners. Each year our Annual Leadership Awards celebrate colleagues who push boundaries to achieve exceptional results. From delivering for our customers to streamlining complex processes and driving innovation, our 2025 award winners exemplified resilience, agility, and perseverance. Their accomplishments made a significant impact on our customers, our company and our world and we can't wait to see what they do next. Congratulations to all of this year's honorees!

A life-threatening allergic reaction to a hot dog with ketchup and mustard left Lidia de Los Rios struggling to breathe when she was 10. This was the start of a series of dangerous and puzzling episodes of anaphylaxis that sent her to the emergency room and countless doctors for more than a decade. With no clear answers for what was causing her condition, Lidia's diet became so restricted that her weight dropped to 81 pounds, and she developed anxiety, depression and a fear of swallowing. Then she met a doctor who changed her life after he administered Thermo Fisher’s ImmunoCAP test, which identified Lidia’s allergy to the lipid transfer protein. This diagnosis helped her doctor develop a new treatment plan that over time enabled her to eat foods that once would have killed her, transforming both her physical and mental health. Lidia's story is a testament to the impact of precise diagnosis and patient-tailored treatment to change people’s lives.

On World Cancer Day, we honor the healthcare providers, researchers, and innovators who offer vital support to patients, tirelessly seek new therapies and develop cutting-edge technologies that help make treatment more effective and accessible. We are proud to support these dedicated professionals in their mission with our instruments and technology that are designed to help identify new cancer biomarkers, effectively diagnose patients to inform personalized treatment plans and match patients with the right clinical trials. Read more here: https://lnkd.in/gVUdXhFg

A new agreement enables us to power all our addressable European sites with 100 percent renewable energy—a key milestone on our journey to net-zero emissions by 2050. Together with GSK, Gilead Sciences and Haleon, we’ve entered a 118-megawatt virtual power purchase agreement with X-ELIO that increases access to renewable electricity across the pharmaceutical and healthcare supply chains. We're honored to lead our value chain partners in this agreement and to benefit from the support of the Energize initiative, managed by Schneider Electric Sustainability Business and PSCI - Pharmaceutical Supply Chain Initiative. When we work together to reach our ambitious climate targets, we accelerate our progress toward a healthier planet. Read more: https://lnkd.in/g87eCwQs

Marc Casper, chairman, president and CEO, joined Mad Money to discuss our Q4 and full-year 2024 earnings results, driven by new innovations and investments that make us a trusted partner for our customers. Watch the full interview: https://lnkd.in/gb8Sgswq

Cell therapies use a patient’s own immune system to fight complex diseases like cancer, but time and cost impede access to these potentially life-saving treatments. These are precisely the challenges that Thermo Fisher is working to help our customers overcome. Our own Jean Luo joined miDiagnositic’s CEO to discuss the ways our organizations collaborate to help scientists advance research, scale manufacturing through automation and accelerate patient access to cell therapies through our clinical trial services. “By leveraging this collective expertise and experience, we collaborate with regulators, as well as companies and customers, to bring cell therapies to market faster,” says Luo. Hear more from Luo about this important work: https://lnkd.in/g9HPPVY6